Pamela J Weathers
Biographic Data
| ID | 7258340 |
|---|---|
| NAME | Pamela J Weathers |
| GIVEN NAMES | Pamela J |
| FAMILY NAME | Weathers |
| SIGNATURE | WEATHERS P J |
| AFFILIATIONS | Worcester Polytechnic Institute |
| ORCID | 0000-0001-5138-3839 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
An O-methylflavone from Artemisia afra kills non-replicating hypoxic Mycobacterium tuberculosis
The present study demonstrated that an O-methylflavone constituent of Artemisia afra explains part of the activity of this plant against Mtb. This result contributes to a mechanistic understanding of the reported anti-tubercular activity of A. afra and highlights the need for further study of this traditional medicinal plant and its active compounds
Sars-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts
A. annua hot-water extracts (tea infusions) continue to show efficacy against SARS-CoV-2 and its rapidly evolving variants and deserve greater attention as a possible cost-effective therapeutic
Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta
Artemisia extracts differ from artemisinin effects on human hepatic CYP450s 2B6 and 3A4 in vitro
In vitro reduction of Plasmodium falciparum gametocytes
Artemisia annua L. extracts inhibit the in vitro replication of Sars-CoV-2 and two of its variants
Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis
Our results indicate that Artemisia extracts have an enormous potential for treatment of TB and M. abscessus infections, and that these plants contain bactericidal compounds in addition to AN. Combination of extracts with existing antibiotics may not only improve treatment outcomes but also reduce the emergence of resistance to other drugs
Artemisinin permeability via Caco-2 cells increases after simulated digestion of Artemisia annua leaves
Effect of leaf digestion and artemisinin solubility for use in oral consumption of dried Artemisia annua leaves to treat malaria
Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected mice
Simulated digestion of dried leaves of Artemisia annua consumed as a treatment (pACT) for malaria
No prominent works on this page.
Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected mice
Simulated digestion of dried leaves of Artemisia annua consumed as a treatment (pACT) for malaria
Effect of leaf digestion and artemisinin solubility for use in oral consumption of dried Artemisia annua leaves to treat malaria
Artemisinin permeability via Caco-2 cells increases after simulated digestion of Artemisia annua leaves
Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis
Our results indicate that Artemisia extracts have an enormous potential for treatment of TB and M. abscessus infections, and that these plants contain bactericidal compounds in addition to AN. Combination of extracts with existing antibiotics may not only improve treatment outcomes but also reduce the emergence of resistance to other drugs
In vitro reduction of Plasmodium falciparum gametocytes
Artemisia annua L. extracts inhibit the in vitro replication of Sars-CoV-2 and two of its variants
Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta
Artemisia extracts differ from artemisinin effects on human hepatic CYP450s 2B6 and 3A4 in vitro
Sars-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts
A. annua hot-water extracts (tea infusions) continue to show efficacy against SARS-CoV-2 and its rapidly evolving variants and deserve greater attention as a possible cost-effective therapeutic
An O-methylflavone from Artemisia afra kills non-replicating hypoxic Mycobacterium tuberculosis
The present study demonstrated that an O-methylflavone constituent of Artemisia afra explains part of the activity of this plant against Mtb. This result contributes to a mechanistic understanding of the reported anti-tubercular activity of A. afra and highlights the need for further study of this traditional medicinal plant and its active compounds
Artemisia annua (10 works) · Artemisinin (10 works) · Immunology (10 works) · Malaria (10 works) · Medicine (10 works) · Plasmodium falciparum (10 works) · Biology (9 works) · Traditional medicine (9 works) · Malaria Research and Control (6 works) · Artemisia (5 works)